Alan Walts
Direktor/Vorstandsmitglied bei ELOXX PHARMACEUTICALS, INC.
Vermögen: 739 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Raj Bhikhu Parekh | M | 63 |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA.
Advent Life Sciences LLP
 Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry.
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA.
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 19 Jahre |
| Sumit Aggarwal | M | - |
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | 6 Jahre |
| Michael Gilman | M | 69 |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA.
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | 10 Jahre |
| Sun Altbach | F | - |
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA.
Termeer Foundation
| 6 Jahre |
| Daniel Geffken | M | 67 |
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA.
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | 5 Jahre |
| Carulla Tormo | M | - |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | - |
| Katherine Bowdish | M | 67 |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | 4 Jahre |
| Fiona MacLaughlin | M | - |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA.
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | 12 Jahre |
| Rob W. Armstrong | M | 67 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | 11 Jahre |
| Karen LaRochelle | F | 57 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA.
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry.
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 4 Jahre |
| Andre Hoekema | M | 67 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | 1 Jahre |
| Belinda Herrera Termeer | F | - |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA.
Termeer Foundation
| - |
| Barbara Ryan | F | - | - | |
| Jennifer C. Petter | M | - |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | 9 Jahre |
| Mohammed Malik | M | 56 |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry.
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 25 Jahre |
| Steven Rubin | M | 63 | 10 Jahre | |
| Ana Maiques Valls | F | - |
Neuroelectrics, Inc.
 Neuroelectrics, Inc. Miscellaneous Commercial ServicesCommercial Services Neuroelectrics, Inc. is a company that is developing a therapeutic platform for the treatment of neurological and psychiatric disorders. The company is based in Cambridge, MA and Barcelona, Spain. The company's platform uses neuromodulation, which combines safe and proven neuromodulation capabilities with remote-controlled delivery and personalized treatment protocols to restore and maintain brain health. Neuroelectrics has an expanding pipeline of computationally driven solutions for neurologic and psychiatric disorders. The company was founded by Ana Maiques Valls and Giulio Ruffini, and Ana Maiques Valls has been the CEO since incorporation. | - |
| John H. Rex | M | - |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 9 Jahre |
| Ian James Nicholson | M | 64 |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry.
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 12 Jahre |
| Giulio Ruffini | M | - |
Neuroelectrics, Inc.
Neuroelectrics, Inc. Miscellaneous Commercial ServicesCommercial Services Neuroelectrics, Inc. is a company that is developing a therapeutic platform for the treatment of neurological and psychiatric disorders. The company is based in Cambridge, MA and Barcelona, Spain. The company's platform uses neuromodulation, which combines safe and proven neuromodulation capabilities with remote-controlled delivery and personalized treatment protocols to restore and maintain brain health. Neuroelectrics has an expanding pipeline of computationally driven solutions for neurologic and psychiatric disorders. The company was founded by Ana Maiques Valls and Giulio Ruffini, and Ana Maiques Valls has been the CEO since incorporation. | - |
| Lindsay Androski | F | - | 2 Jahre | |
| Gerhard Wagner | M | - |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | - |
| Andres Gagete | M | - |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | - |
| Philomena Lip | F | - |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 3 Jahre |
| Ali Hariri | M | - | 3 Jahre | |
| Julie Feder | F | 54 | 6 Jahre | |
| Majid Kazmi | M | - |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | - |
| Dominic Schmidt | M | 42 |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 2 Jahre |
| Saiyed Mahmood | M | 48 |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 19 Jahre |
| Jonathan Moore | M | 57 |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 6 Jahre |
| Gail Maderis | F | 66 |
Termeer Foundation
| - |
| J. David Litster | M | 85 |
Massachusetts Institute of Technology
| 41 Jahre |
| John F. Rockart | M | 92 |
Massachusetts Institute of Technology
| 42 Jahre |
| Donald Lee Drakeman | M | 70 |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 17 Jahre |
| John Maraganore | M | 60 |
Termeer Foundation
| - |
| Katrine Bosley | F | 56 |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 2 Jahre |
| Simon Kerry | M | - |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 7 Jahre |
| Alain Huriez | M | 62 |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 12 Jahre |
| Ahmed Ghoniem | M | 72 |
Massachusetts Institute of Technology
| 41 Jahre |
| Christopher Viehbacher | M | 64 |
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | 7 Jahre |
| Richard Young | M | 70 |
Massachusetts Institute of Technology
| 40 Jahre |
| Simona Heidempergher | F | 56 |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | - |
| Roy R. Lobb | M | - |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 9 Jahre |
| Gino Santini | M | 66 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | 10 Jahre |
| Monique Schiersing | M | - |
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | - |
| Satish Jindal | M | - |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 2 Jahre |
| Fraser Murray | M | 53 |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Paula Ragan | M | 54 |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | - |
| Gregory C. Williams | M | 65 | 3 Jahre | |
| John S. Langford | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
| Silvia Noiman | M | 68 | 4 Jahre | |
| Morris Kesler | M | - |
Massachusetts Institute of Technology
| 8 Jahre |
| Tomer Kariv | M | 62 | 6 Jahre | |
| Mark A. Clements | M | - |
Massachusetts Institute of Technology
| 3 Jahre |
| Yoo-Hwan Jang | M | 69 |
Massachusetts Institute of Technology
| 3 Jahre |
| Jerry L. Prince | M | - |
Massachusetts Institute of Technology
| 10 Jahre |
| Richard Peters | M | 61 |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA.
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | 6 Jahre |
| Neil S. Belloff | M | 64 | 3 Jahre | |
| Henri A. Termeer | M | 78 |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA.
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | - |
| Joseph Lobacki | M | 65 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | 4 Jahre |
| Jocelyn E. Scott | F | - |
Massachusetts Institute of Technology
| 4 Jahre |
| Kong Ann Soon | M | 68 |
Massachusetts Institute of Technology
| 5 Jahre |
| Ran Nussbaum | M | 51 | 5 Jahre | |
| Brad Feld | M | 58 |
Massachusetts Institute of Technology
| 5 Jahre |
| Gadi Veinrib | M | 45 | 5 Jahre | |
| Sahba S. Vaziri | F | - |
Massachusetts Institute of Technology
| 6 Jahre |
| Barbara Poggiali | M | 61 |
Massachusetts Institute of Technology
| 5 Jahre |
| Mark Gus Alexandridis | M | 66 |
Massachusetts Institute of Technology
| 6 Jahre |
| Mark Jennings | M | 63 |
Massachusetts Institute of Technology
| 5 Jahre |
| Warren Chou | M | - |
Massachusetts Institute of Technology
| 6 Jahre |
| Kyu-Ha Cung | M | 72 |
Massachusetts Institute of Technology
| 7 Jahre |
| Zafrira Avnur | M | 73 | 5 Jahre | |
| Laura A. Lane | F | - |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 3 Jahre |
| Javier de Luis | M | - |
Massachusetts Institute of Technology
| 6 Jahre |
| Thomas H. Lee | M | 64 |
Massachusetts Institute of Technology
| 6 Jahre |
| Gregg Burgess | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
| Michael H. Chalfen | M | - |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | 6 Jahre |
| Christopher J. Neil | M | 58 |
Massachusetts Institute of Technology
| 6 Jahre |
| Philippe Laffont | M | - |
Massachusetts Institute of Technology
| 6 Jahre |
| Brian Jacobs | M | 63 |
Massachusetts Institute of Technology
| 5 Jahre |
| Kei Yamamoto | F | - |
Massachusetts Institute of Technology
| 5 Jahre |
| Elizabeth Marie Robinson | M | - |
Massachusetts Institute of Technology
| 4 Jahre |
| Martijn Kleijwegt | M | 69 | 4 Jahre | |
| Sameer Gandhi | M | 58 |
Massachusetts Institute of Technology
| 15 Jahre |
| Joe Schirripa | M | - |
Massachusetts Institute of Technology
| 6 Jahre |
| Mike McElroy | M | - |
Massachusetts Institute of Technology
| 9 Jahre |
| Spiros Jamas | M | 63 |
Massachusetts Institute of Technology
| 5 Jahre |
| Russell C. Petter | M | - |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | - |
| John A. DeTore | M | - |
Massachusetts Institute of Technology
| 7 Jahre |
| Jasbir Seehra | M | 68 | 4 Jahre | |
| Ken Kharbanda | M | - |
Massachusetts Institute of Technology
| 3 Jahre |
| Jon Hirschtick | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
| Ford Tamer | M | 62 |
Massachusetts Institute of Technology
| 5 Jahre |
| Suresh Thirugnanam | M | 60 |
Massachusetts Institute of Technology
| 4 Jahre |
| Subodh Kulkarni | M | 60 |
Massachusetts Institute of Technology
| 4 Jahre |
| Michael Wyzga | M | 69 |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | 2 Jahre |
| Gary D Rakers | M | - | 1 Jahre | |
| Ulrich W. Suter | M | 80 |
Massachusetts Institute of Technology
| 7 Jahre |
| Dillon F. Robert | M | - |
Massachusetts Institute of Technology
| 4 Jahre |
| Noubar Afeyan | M | 60 |
Massachusetts Institute of Technology
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 82 | 82,00% |
| Vereinigtes Königreich | 21 | 21,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Alan Walts
- Persönliches Netzwerk
